This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies
Cell Death Discovery Open Access 17 July 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Liu, H. et al. Targeting tumour-intrinsic N7-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy. Gut https://doi.org/10.1136/gutjnl-2022-327230 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kotsiliti, E. Targeting hyperactive tRNA modification improves anti-PD1 efficacy. Nat Rev Gastroenterol Hepatol 20, 3 (2023). https://doi.org/10.1038/s41575-022-00715-6
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41575-022-00715-6
This article is cited by
-
Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies
Cell Death Discovery (2024)
